Position in IBRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$298,439
+$221,398 QoQ
Shares Held
38,910
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026One Capital Management, LLC holds $31,474,352 across 8 Biotechnology names. IBRX ranks #6 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,368 | $17,282,411 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
58,939 | $4,425,729 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
61,681 | $3,986,443 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
13,847 | $2,764,553 | |
| 5 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
94,731 | $2,345,539 | |
| 6 | IBRX |
ImmunityBio, Inc.
This page
|
38,910 | $298,439 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
664 | $296,502 | |
| 8 | GNLX |
GENELUX Corp
|
30,883 | $74,736 |
All Filings in IBRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $298,439 | 38,910 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $77,041 | 38,910 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $95,718 | 38,910 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $102,722 | 38,910 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||